Outcome and Clinical Significance of Immunophenotypic Markers Expressed in Different Treatment Protocols of Pediatric Patients With T-ALL in Developing Countries.

Saved in:
Bibliographic Details
Title: Outcome and Clinical Significance of Immunophenotypic Markers Expressed in Different Treatment Protocols of Pediatric Patients With T-ALL in Developing Countries.
Authors: Sayed DM; Clinical Pathology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt. Electronic address: douaa@aun.edu.eg., Sayed HAR; Pediatric Oncology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt., Raslan HN; Laboratory Department, King Fahad Specialist Hospital, Dammam, Kingdom of Saudi Arabia., Ali AM; Pediatric Oncology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt., Zahran A; Clinical Pathology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt., Al-Hayek R; Pediatric Oncology Department, King Fahad Specialist Hospital, Dammam, Kingdom of Saudi Arabia., Daama SA; Pediatric Oncology Department, King Fahad Specialist Hospital, Dammam, Kingdom of Saudi Arabia., Al-Saber A; Laboratory Department, King Fahad Specialist Hospital, Dammam, Kingdom of Saudi Arabia.
Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2017 Jul; Vol. 17 (7), pp. 443-449. Date of Electronic Publication: 2017 May 10.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2152-2669
DOI:10.1016/j.clml.2017.05.012